Clinical Trials Arena February 20, 2025
Abigail Beaney

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine’s Day weekend.

Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at US healthcare agencies, with many sharing their dismay and fear about the impact it could have on device and drug approvals.

Last weekend, over 5,200 probationary staff from agencies within the Department of Health and Human Services (HHS), including staff from the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and the National Institute of Health (NIH), were hit by job cuts due to Department of Government Efficiency (DOGE) cutbacks.

The CDC’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, HHS, Medical Devices, Pharma, Pharma / Biotech
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO
Device industry scrambles amid concern FDA layoffs will cause delays
Avante appoints new CEO under Staple Street ownership
Micro-X gets $16 million contract to develop mobile full-body CT
The transformation imperative: Igniting value creation in medtech

Share This Article